UK Innovation & Science Seed Fund News

Co-sell partnership to provide unparalleled access to Microsoft’s Enterprise customers Eagle Genomics solution enables assessment of viability, efficacy and safety of enterprise branded products Driving digital reinvention of life sciences using artificial intelligence to map the microbiome LONDON [date], Eagle Genomics joins a specialised group of high-growth startups, earning co-sell status as part of Microsoft’s […]

read more

Acquisition furthers Astellas’ commitment to innovation in ophthalmology with addition of novel gene therapy program for glaucoma TOKYO, CAMBRIDGE (UK), August 10, 2018 – Astellas Pharma Inc. (TSE: 4503, President and CEO: Kenji Yasukawa,Ph.D., “Astellas”) and Quethera Limited (CEO: Peter Widdowson, Ph.D., “Quethera”) today announced that Astellas has acquired Quethera, a gene therapy company headquartered […]

read more

UK Innovation & Science Seed Fund (UKI2S) and Imperial Innovations announce the launch of Cagen, a company focused on innovative uses of protein nanocages. Founded by Dr Geoff Baldwin, Reader in Biochemistry at Imperial College London, Cagen has developed self-assembling protein nanocages which can be used to carry drugs within the body. These nanocages can […]

read more

1 2 3 4 25